Search research articles
Contact Us
Filters
Showing results (451-460 of 487) with videos related to
Page
of 49
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
April 7, 2023
Use and outcome of minimally invasive pancreatic surgery in the European E-MIPS registry
Nicky van der Heijde, Frederique L Vissers, Alberto Manzoni, et al.
BMJ Open
|
July 16, 2025
STRONG II trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma - a single-arm multicentre phase II study
Suus Y van Loosbroek, Maaike T W Milder, Dirk de Ruysscher, et al.
JAMA Oncology
|
September 10, 2020
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment
Stijn van Roessel, Eran van Veldhuisen, Sjors Klompmaker, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
August 24, 2019
The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis
Tara M Mackay, F Jasmijn Smits, Daphne Roos, et al.
Annals of Surgery
|
July 21, 2022
Robotic Distal Pancreatectomy: A Novel Standard of Care? Benchmark Values for Surgical Outcomes From 16 International Expert Centers
Philip C Müller, Eva Breuer, Felix Nickel, et al.
The British Journal of Surgery
|
November 28, 2025
Oncological outcome after robot-assisted versus open pancreatoduodenectomy for upfront resectable cancer in the pancreatic head: a nationwide cohort analysis
Julia E Menso, Caro L Bruna, Mahsoem Ali, et al.
BJS Open
|
June 9, 2026
Impact of preoperative radiotherapy on the risk of postpancreatectomy haemorrhage and major morbidity after resection of pancreatic adenocarcinoma including arterial divestment or arterial resection
Thomas F Stoop, Freek R van 't Land, Leonard W F Seelen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2022
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial
Eva Versteijne, Jacob L van Dam, Mustafa Suker, et al.
Annals of Surgery
|
January 31, 2025
Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX
Ingmar F Rompen, Thomas F Stoop, Stijn van Roessel, et al.
United European Gastroenterology Journal
|
June 5, 2026
Endoscopic Ultrasonography-Guided Gastroenterostomy Is More Cost Effective Than Surgical Gastrojejunostomy: A Health-Economic Evaluation Alongside a Randomized Trial
Yorick L van de Pavert, Kirsten Opmeer, Marc G Besselink, et al.
Page
of 49
Search research articles
Search
Showing results (451-460 of 487) with videos related to
Sort By:
Page
of 49
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
April 7, 2023
Use and outcome of minimally invasive pancreatic surgery in the European E-MIPS registry
Nicky van der Heijde, Frederique L Vissers, Alberto Manzoni, et al.
BMJ Open
|
July 16, 2025
STRONG II trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma - a single-arm multicentre phase II study
Suus Y van Loosbroek, Maaike T W Milder, Dirk de Ruysscher, et al.
JAMA Oncology
|
September 10, 2020
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment
Stijn van Roessel, Eran van Veldhuisen, Sjors Klompmaker, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
August 24, 2019
The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis
Tara M Mackay, F Jasmijn Smits, Daphne Roos, et al.
Annals of Surgery
|
July 21, 2022
Robotic Distal Pancreatectomy: A Novel Standard of Care? Benchmark Values for Surgical Outcomes From 16 International Expert Centers
Philip C Müller, Eva Breuer, Felix Nickel, et al.
The British Journal of Surgery
|
November 28, 2025
Oncological outcome after robot-assisted versus open pancreatoduodenectomy for upfront resectable cancer in the pancreatic head: a nationwide cohort analysis
Julia E Menso, Caro L Bruna, Mahsoem Ali, et al.
BJS Open
|
June 9, 2026
Impact of preoperative radiotherapy on the risk of postpancreatectomy haemorrhage and major morbidity after resection of pancreatic adenocarcinoma including arterial divestment or arterial resection
Thomas F Stoop, Freek R van 't Land, Leonard W F Seelen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2022
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial
Eva Versteijne, Jacob L van Dam, Mustafa Suker, et al.
Annals of Surgery
|
January 31, 2025
Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX
Ingmar F Rompen, Thomas F Stoop, Stijn van Roessel, et al.
United European Gastroenterology Journal
|
June 5, 2026
Endoscopic Ultrasonography-Guided Gastroenterostomy Is More Cost Effective Than Surgical Gastrojejunostomy: A Health-Economic Evaluation Alongside a Randomized Trial
Yorick L van de Pavert, Kirsten Opmeer, Marc G Besselink, et al.
Page
of 49